RG
APYX icon

Rathbones Group’s Apyx Medical APYX Stock Holding History

Rathbones Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,334
Closed -$139K – 629
2025
Q1 		$139K Hold
101,334
– – ﹤0.01% 551
2024
Q4 		$160K Sell
101,334
-150,000
-60% -$210K ﹤0.01% 548
2024
Q3 		$312K Hold
251,334
– – ﹤0.01% 477
2024
Q2 		$337K Buy
251,334
+150,000
+148% +$221K ﹤0.01% 467
2024
Q1 		$138K Hold
101,334
– – ﹤0.01% 564
2023
Q4 		$265K Hold
101,334
– – ﹤0.01% 489
2023
Q3 		$324K Buy
+101,334
New +$472K ﹤0.01% 462

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rathbones Group's APYX Position: Q2 2025 in Review

Rathbones Group sold out of Apyx Medical (APYX) in Q2 2025, closing a stake of 101,334 shares — an estimated $139K sold.

Rathbones Group first reported a position in APYX in Q3 2023 and held it in 7 quarters. The position peaked at $337K in Q2 2024. 39 funds tracked by Wall St. Rank hold APYX as of Q2 2025.

  • Rathbones Group reported no remaining Apyx Medical position as of Q2 2025 after selling out during the quarter.
  • Rathbones Group sold 101,334 Apyx Medical shares in Q2 2025, an estimated $139K.
  • Rathbones Group first reported a position in Apyx Medical in Q3 2023 and held it in 7 quarters.
  • Rathbones Group's Apyx Medical position peaked at $337K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2025.

Based on Rathbones Group's 13F filing for Q2 2025, filed 7 Aug 2025.